Synthroid and Mephyton drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Synthroid (levothyroxine sodium) and Mephyton (phytonadione). Common drug interactions include nephrogenic anaemia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Synthroid and Mephyton. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,198 Synthroid users. Check the latest studies of Synthroid.

What is Mephyton?

Mephyton has active ingredients of phytonadione. eHealthMe is studying from 1,006 Mephyton users. Check the latest studies of Mephyton.



On Jul, 20, 2026

38 people who take Synthroid and Mephyton together, and have interactions are studied.

Synthroid and Mephyton drug interactions.

What are the common drug interactions of Synthroid and Mephyton, by gender? *:

female:

  1. Nephrogenic anaemia (anaemia due to kidney disease)
  2. Nervousness
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Oedema peripheral (superficial swelling)
  5. Oesophageal varices haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus)
  6. Overdose
  7. Oxygen saturation decreased
  8. Pain in extremity
  9. Pancarditis (inflammation of the entire heart)
  10. Pancreatitis (inflammation of pancreas)

male:

  1. Pneumonia
  2. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  3. Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
  4. Pleural effusion (water on the lungs)
  5. Pyrexia (fever)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Anaemia (lack of blood)
  8. Cardiac failure congestive
  9. Herpes zoster
  10. International normalised ratio increased

What are the common drug interactions of Synthroid and Mephyton, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pancarditis (inflammation of the entire heart)
  2. Pancreatitis (inflammation of pancreas)

20-29:

n/a

30-39:

n/a

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Heart rate increased
  3. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  4. Thyroid cancer

50-59:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Back pain
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cardiac disorder
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Death
  8. Insomnia (sleeplessness)
  9. International normalised ratio increased
  10. Jugular vein thrombosis (clot in jugular vein)

60+:

  1. Acute respiratory failure
  2. Hypotension (abnormally low blood pressure)
  3. Adverse drug reaction
  4. Ankle fracture
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Drug ineffective
  7. Hepatic neoplasm malignant (liver cancer)
  8. Herpes zoster
  9. Limb injury
  10. Weakness

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 23.68%
  2. High Blood Pressure: 8 people, 21.05%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 15.79%
  4. Diabetes: 6 people, 15.79%
  5. High Blood Cholesterol: 6 people, 15.79%
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 5 people, 13.16%
  7. Fungal Infection: 5 people, 13.16%
  8. Psoriasis (immune-mediated disease that affects the skin): 5 people, 13.16%
  9. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 13.16%
  10. Cystic Fibrosis (disease of the secretary glands): 4 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Synthroid and Mephyton?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Synthroid and Mephyton:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mephyton:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synthroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mephyton and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and phytonadione (the active ingredients of Synthroid and Mephyton, respectively), and Synthroid and Mephyton (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: